search
Back to results

A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation

Primary Purpose

Atrial Fibrillation

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Bipolar radiofrequency ablation
Sponsored by
Norwegian University of Science and Technology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atrial Fibrillation focused on measuring Catheter ablation, Heart/surgery, Cardial surgical procedures

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: referred for elective heart surgery with extracorporeal circulation suffers from AF for more than 6 months but less than 7 years aged between 18 and 80 years ejection fraction above 30 % Exclusion Criteria: Reoperations NYHA class IV Ischemic mitral incompetence Creatinine > 140 Transmural myocardial infarction < 4 weeks Endocarditis Serious peripheral vascular disease Pregnancy or breast-feeding Drug addiction Size of left atrium > 60 mm in preoperative echo-doppler investigation. Disease or other condition when the patient is unable to understand the objectives and the scope of the study.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Bipolar radiofrequency ablation

    Arm Description

    Outcomes

    Primary Outcome Measures

    Number of patients in sinus rhythm after 3, 6, and 12 months
    Number of patients with atrial function at echo-doppler after 6 and 12 months
    Number of patients on anticoagulants after 6 and 12 months

    Secondary Outcome Measures

    Full Information

    First Posted
    September 13, 2005
    Last Updated
    March 18, 2015
    Sponsor
    Norwegian University of Science and Technology
    Collaborators
    St. Olavs Hospital, Oslo University Hospital, Haukeland Sykehus HF, Ullevaal University Hospital, Regionssykehuset i Tromsø HF, Feiringklinikken
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00184249
    Brief Title
    A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation
    Official Title
    A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2015
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Collaborators did not enter patients into the study
    Study Start Date
    June 2005 (undefined)
    Primary Completion Date
    June 2010 (Actual)
    Study Completion Date
    June 2012 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Norwegian University of Science and Technology
    Collaborators
    St. Olavs Hospital, Oslo University Hospital, Haukeland Sykehus HF, Ullevaal University Hospital, Regionssykehuset i Tromsø HF, Feiringklinikken

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The study is a prospective multi-centre study to investigate the effect of a new bipolar ablation strategy of the left atrium in patients with paroxysmal or permanent atrial fibrillation over time.
    Detailed Description
    Atrial fibrillation (AF) is the most common persistent arrhythmia, prevalent in about 6% of the population over 65 years of age. AF reduces the quality of life and increases mortality. AF is particularly common in combination with mitral valve disease, but is also detected in about 5% of patients with aortic valve and coronary artery disease. Surgical treatment of AF with the Cox-maze III operation was developed by J. Cox during the 80ies. The aim of the operation is to block spread of irregular electrical activity by creating lines of isolation in the atrial musculature. The operation achieves sinus rhythm in over 90% in selected patients. Nevertheless the method was only used in few heart surgical centres, because it is complex and time consuming.In recent years alternative energy sources have been developed to create isolating lines without cutting the tissue and thus making ablation treatment easier. Bipolar radiofrequency ablation is special because the energy is delivered feedback controlled until transmurality is achieved. This is a prerequisite for a good result and makes using the equipment safer. Since the development of the Cox-maze procedure, our knowledge of atrial fibrillation and its treatment has increased considerably. There is a consensus that the posterior part of the left atrium and in particular the pulmonary veins are an important target for treatment. Surgical ablation with alternative energy sources is a new method under continued development and evaluation. The optimal ablation treatment is unknown. A balance between invasiveness and achieving sinus rhythm in as many as possible has to be found. Creating numerous ablation lines in both atria is time consuming and leads probably to an increased need for permanent pacemaker implantation and reduced contractility of the atrial tissue. On the other hand can a simple bipolar ablation of pulmonary veins performed easily, but this is probably an insufficient treatment for most patients. In the protocol a new method using solely bipolar ablation for creation of several ablation lines in the left atrium is described. The study is a prospective multi-centre study to investigate the effect of a new bipolar ablation strategy of the left atrium in patients with paroxysmal or permanent AF over time.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Atrial Fibrillation
    Keywords
    Catheter ablation, Heart/surgery, Cardial surgical procedures

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Bipolar radiofrequency ablation
    Arm Type
    Experimental
    Intervention Type
    Procedure
    Intervention Name(s)
    Bipolar radiofrequency ablation
    Other Intervention Name(s)
    Cardioblade, Atricure
    Intervention Description
    Ablation using CE marked bipolar ablation devices
    Primary Outcome Measure Information:
    Title
    Number of patients in sinus rhythm after 3, 6, and 12 months
    Time Frame
    3, 6,
    Title
    Number of patients with atrial function at echo-doppler after 6 and 12 months
    Time Frame
    3,6, 12 months
    Title
    Number of patients on anticoagulants after 6 and 12 months
    Time Frame
    6 and 12 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: referred for elective heart surgery with extracorporeal circulation suffers from AF for more than 6 months but less than 7 years aged between 18 and 80 years ejection fraction above 30 % Exclusion Criteria: Reoperations NYHA class IV Ischemic mitral incompetence Creatinine > 140 Transmural myocardial infarction < 4 weeks Endocarditis Serious peripheral vascular disease Pregnancy or breast-feeding Drug addiction Size of left atrium > 60 mm in preoperative echo-doppler investigation. Disease or other condition when the patient is unable to understand the objectives and the scope of the study.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Alexander Wahba, Prof
    Organizational Affiliation
    Norwegian University of Science and Technology
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Learn more about this trial

    A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation

    We'll reach out to this number within 24 hrs